Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)
Clinical trial NCT03046056 · COMPLETED
Trial details
- NCT number
- NCT03046056
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-11
- Primary completion
- 2020-07-20
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.